Fengli Li
Impact in
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Epidemiology 40
- Acute Ischemic Stroke Management 34
- Pharmacology 30
- Microbial Natural Products and Biosynthesis 27
- Fungal Biology and Applications 13
- Co-authors
- Zhengxi Hu (32 shared papers)Yonghui Zhang (34 shared papers)Jianping Wang (24 shared papers)Yan Zhang (3 shared papers)Xinbing Wei (3 shared papers)Fan Yi (3 shared papers)Ziying Wang (3 shared papers)Fan Yang (2 shared papers)
- Journals
- Bioorganic Chemistry (8 papers)Organic Letters (7 papers)Journal of NeuroInterventional Surgery (5 papers)Journal of Natural Products (4 papers)Phytochemistry (3 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Fengli Li
99 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 123
- Pharmacology 542
- Neurology 209
- Biotechnology 216
- Internal Medicine 44
- Molecular Biology 676
Countries citing papers authored by Fengli Li
This map shows the geographic impact of Fengli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengli Li more than expected).
Fields of papers citing papers by Fengli Li
This network shows the impact of papers produced by Fengli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengli Li. The network helps show where Fengli Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengli Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 365 | |
| 2 | 2018 | 79 | |
| 3 | 2019 | 59 | |
| 4 | 2018 | 55 | |
| 5 | 2018 | 53 | |
| 6 | 2013 | 53 | |
| 7 | 2018 | 50 | |
| 8 | 2018 | 38 | |
| 9 | 2019 | 38 | |
| 10 | 2023 | 34 | |
| 11 | 2018 | 33 | |
| 12 | 2018 | 33 | |
| 13 | 2017 | 32 | |
| 14 | 2019 | 30 | |
| 15 | 2020 | 30 | |
| 16 | 2013 | 29 | |
| 17 | 2019 | 29 | |
| 18 | 2021 | 27 | |
| 19 | 2020 | 27 | |
| 20 | 2018 | 26 |
About Fengli Li
Fengli Li is a scholar working on Epidemiology, Pharmacology, Molecular Biology, Pulmonary and Respiratory Medicine and Rehabilitation, having authored 105 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (34 papers), Microbial Natural Products and Biosynthesis (27 papers), Cerebrovascular and Carotid Artery Diseases (18 papers), Fungal Biology and Applications (13 papers), Stroke Rehabilitation and Recovery (11 papers), Venous Thromboembolism Diagnosis and Management (9 papers), Marine Sponges and Natural Products (8 papers) and Traumatic Brain Injury and Neurovascular Disturbances (8 papers). The work is most often cited by research in Pharmacology (542 citations), Neurology (209 citations), Biotechnology (216 citations), Internal Medicine (44 citations) and Molecular Biology (676 citations). Fengli Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Zhengxi Hu, Yonghui Zhang, Jianping Wang, Yan Zhang, Xinbing Wei, Fan Yi, Ziying Wang, Fan Yang, Weichen Shi and Tao Xin. Their work appears in journals such as Bioorganic Chemistry, Organic Letters, Journal of NeuroInterventional Surgery, Journal of Natural Products and Phytochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.